Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetics and personalized medicine in antidepressant treatment.

Current pharmaceutical design - 1 Jan 2012

Gvozdic Katarina, Brandl Eva J, Taylor Danielle L, Müller Daniel J

Abstract excerpt

BACKGROUND: Antidepressant medication is a major cornerstone in treatment of mood and anxiety disorders. Numerous substances are available on the market; however, only 60% of treated patients show sufficient response to medication and side effects are common. Lengthy trials are not uncommon until the optimized drug and dose is found and unfortunately, no valid predictors to match the 'right' drug to the 'right'...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antidepressive Agents
Share to Depression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Selection

Share to Pharmacogenetics

Share to Precision Medicine

Share to Treatment Outcome

Share to Young Adult

Source

Identifiers

PMID: 22681166
DOI: 10.2174/138161212803523617

Genes

ABCB1
HTT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetics and personalized medicine in antidepressant treatment.PMID 22681166Read ↗

The role of pharmacogenetics in the treatment of depression and anxiety disorders.Semantic proximity Read ↗

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.Semantic proximity Read ↗

Pharmacogenomics of antidepressant drugs.Semantic proximity Read ↗

Pharmacogenetic studies: a tool to improve antidepressant therapy.Semantic proximity Read ↗

Antidepressant pharmacogeneticsSemantic proximity Read ↗

Pharmacogenomics and antidepressant drugs.Semantic proximity Read ↗

Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.Semantic proximity Read ↗

Serotonin Pathway Polymorphisms and the Treatment of Major Depressive Disorder and Anxiety DisordersSemantic proximity Read ↗

Pharmacogenetics of antidepressant response.Semantic proximity Read ↗

Pharmacogenetics of AntidepressantsSemantic proximity Read ↗

Pharmacogenetic considerations in the treatment of psychiatric disorders.Semantic proximity Read ↗

Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.